Diferencia entre revisiones de «Immune thrombocytopenic purpura»
(→Types) |
Sin resumen de edición |
||
| Línea 24: | Línea 24: | ||
==Treatment Options== | ==Treatment Options== | ||
*'''First choice in adults:''' Corticosteroids | |||
**Prednisone 60-100 mg/d with taper after count reaches normal | |||
**Methylprednisolone 30mg/kg/d IV x 3 days (for life-threatening bleeding) | |||
*'''First choice in children:''' Intravenous Immunoglobulin G (IVIG) 1gm/kg/d x 2 days | |||
*Anti-D (RhoGAM): patient must be Rh+ for it to work | |||
*Transfusion (platelets) | |||
**Indicated for life-threatening bleeding | |||
**Transfuse only following first dose of methylprednisolone or IVIG | |||
***Holding transfusion until after first dose results in greater rise in platelet count | |||
*Estrogen for uterine bleeding: 25mg IV x1 | |||
==Treatment Indications== | ==Treatment Indications== | ||
===Adults=== | ===Adults=== | ||
*Plt >30K and asymptomatic: usually do not require treatment | |||
*Plt count <30K: prednisone | |||
*Plt <50K AND bleeding: prednisone | |||
*Life-threatening bleeding: IVIG, methylprednisolone, platelet transfusion | |||
===Children=== | ===Children=== | ||
*Platelet count >30K: usually do not require treatment | |||
*Platelet count <20K + significant bleeding: IVIG | |||
*Platelet count <10K: IVIG | |||
*Life-threatening bleeding: IVIG, methylprednisolone, platelet transfusion | |||
==Disposition== | ==Disposition== | ||
*'''Admit:''' platelet count <20K or significant mucous membrane bleeding | |||
*'''Discharge:''' platelet count >20K AND asymptomatic OR only minor petechiae | |||
==Complications== | ==Complications== | ||
*Rare: more common in elderly | |||
**Intracerebral bleeding | |||
**Severe GI bleeding | |||
==See Also== | ==See Also== | ||
Revisión del 05:07 6 jun 2015
Background
- Acquired autoimmune disease resulting in destruction of platelets
- Because circulating platelets are functional, life-threatening bleeding only once platelet count <10K
Types
- Acute
- More common among younger children
- Affects men/women equally
- Resolves in 1-2 months
- Chronic
- Lasts > 3 months
- More common in adults and women
- Rarely remits spontaneously or with treatment
- More likely to have an underlying disease or autoimmune disorder (e.g. SLE)
Clinical Features
- Petechiae
- Epistaxis, gingival bleeding, menorrhagia
Diagnosis
- Diagnosis of exclusion
- Must differentiate acute ITP from chronic ITP, which suggests an underlying disorder
- CBC shows normal cell lines except for the platelets (may have mild anemia)
Treatment Options
- First choice in adults: Corticosteroids
- Prednisone 60-100 mg/d with taper after count reaches normal
- Methylprednisolone 30mg/kg/d IV x 3 days (for life-threatening bleeding)
- First choice in children: Intravenous Immunoglobulin G (IVIG) 1gm/kg/d x 2 days
- Anti-D (RhoGAM): patient must be Rh+ for it to work
- Transfusion (platelets)
- Indicated for life-threatening bleeding
- Transfuse only following first dose of methylprednisolone or IVIG
- Holding transfusion until after first dose results in greater rise in platelet count
- Estrogen for uterine bleeding: 25mg IV x1
Treatment Indications
Adults
- Plt >30K and asymptomatic: usually do not require treatment
- Plt count <30K: prednisone
- Plt <50K AND bleeding: prednisone
- Life-threatening bleeding: IVIG, methylprednisolone, platelet transfusion
Children
- Platelet count >30K: usually do not require treatment
- Platelet count <20K + significant bleeding: IVIG
- Platelet count <10K: IVIG
- Life-threatening bleeding: IVIG, methylprednisolone, platelet transfusion
Disposition
- Admit: platelet count <20K or significant mucous membrane bleeding
- Discharge: platelet count >20K AND asymptomatic OR only minor petechiae
Complications
- Rare: more common in elderly
- Intracerebral bleeding
- Severe GI bleeding
See Also
Source
- Tintinalli
- UpToDate
